MiRNA synergistic network construction and enrichment analysis for common target genes in small-cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6375-6378

  Zhang, Tie Feng ^a   Cheng, Ke Wen ^b   Shi, Wei Yin ^a   Zhang, Jin Tao ^a   Liu, Ke Di ^a   Xu, Shu Guang ^a   Chen, Ji Quan ^c  

^a Dachang Hospital in Shanghai   (China)

^b Department of Respiratory Medicine   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Mechanism; miRNA synergistic network; Small cell lung cancer

Indexed keywords

MICRORNA;

ARTICLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; LUNG SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; LUNG NEOPLASMS; MICRORNAS; SMALL CELL LUNG CARCINOMA;

EID: 84877085480     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6375     Document Type: Article

References (31)

1. Adamcsek B, Palla G, Farkas IJ, et al (2006). CFinder: locating cliques and overlapping modules in biological networks. Bioinformatics, 22, 1021-3.
2. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, et al (2008). Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res, 6, 1830-40.
3. Anglicheau D, Muthukumar T, Suthanthiran M (2010). MicroRNAs: small RNAs with big effects. Transplantation, 90, 105.
4. Ashburner M, Ball CA, Blake JA, et al (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 25, 25-9.
5. Assenov Y, Ramirez F, Schelhorn SE, et al (2008). Computing topological parameters of biological networks. Bioinformatics, 24, 282-4.
6. Boyerinas B, Park SM, Hau A, et al (2010). The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer, 17, F19-36.
7. Cui Q, Yu Z, Purisima EO, Wang E (2006). Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol, 2, 46.
8. Ding C, Li R, Peng J, et al (2012). A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Exp Ther Med, 3, 689-92.
9. Enright AJ, John B, Gaul U, et al (2003). MicroRNA targets in Drosophila. Genome Biol, 5, R1.
10. Enright AJ, John B, Gaul U, et al (2004). MicroRNA targets in Drosophila. Genome Biol, 5, 1.
11. Garzon R, Calin GA, Croce CM (2009). MicroRNAs in cancer. Ann Rev Med, 60, 167-79.
12. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res, 36, D154-8.
13. Guo L, Liu Y, Bai Y, et al (2010). Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer, 46, 1692-702.
14. Huang da W, Sherman BT, Lempicki RA (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 37, 1-13.
15. Jiang Q, Wang Y, Hao Y, et al (2009). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res, 37, D98-104.
16. Johnson CD, Esquela-Kerscher A, Stefani G, et al (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res, 67, 7713-22.
17. Kanehisa M (2002). The KEGG database. Novartis Found Symp, 247, 91-101; discussion -3, 19-28, 244-52.
18. Killcoyne S, Carter GW, Smith J, Boyle J (2009). Cytoscape: a community-based framework for network modeling. Methods Mol Biol, 563, 219-39.
19. Krek A, Grün D, Poy MN, et al (2005). Combinatorial microRNA target predictions. Nat Genet, 37, 495-500.
20. Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15-20.
21. Li G, Qian T, Li G, et al (2012). Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression. Genet Mol Res, 11, 77-86.
22. Lu M, Zhang Q, Deng M, et al (2008). An analysis of human microRNA and disease associations. PloS one, 3, e3420.
23. Manning G, Whyte DB, Martinez R, et al (2002). The protein kinase complement of the human genome. Sci Signal, 298, 1912.
24. Nasu K, Hirakawa T, Okamoto M, et al (2011). Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery. Rare Tumors, 3, e6.
25. Nau MM, Brooks BJ, Battey J, et al (1985). L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature, 318, 69-73.
26. Navarro A, Marrades RM, Viñolas N, et al (2009). MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. Oncology, 76, 162-9.
27. Ranade AR, Cherba D, Sridhar S, et al (2010). MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol, 5, 1273-8.
28. Roush S, Slack FJ (2008). The let-7 family of microRNAs. Tr cell biol, 18, 505.
29. Xiong F, Wu C, Chang J, et al (2011). Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res, 71, 5175-81.
30. Xu J, Li CX, Li YS, et al (2011). MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic Acids Res, 39, 825-36.
31. Xue M, Cao X, Zhong Y, et al (2012). Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives. Curr Pharm Des, 18, 2901-13.